Northern Trust Corp Royalty Pharma PLC Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Royalty Pharma PLC stock. As of the latest transaction made, Northern Trust Corp holds 2,953,810 shares of RPRX stock, worth $75.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,953,810
Previous 3,297,277 10.42%
Holding current value
$75.9 Million
Previous $86.9 Million 3.89%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$25.63 - $29.27 $8.8 Million - $10.1 Million
-343,467 Reduced 10.42%
2,953,810 $83.6 Million
Q2 2024

Aug 14, 2024
BUY
$26.26 - $29.9 $12.7 Million - $14.5 Million
484,144 Added 17.21%
3,297,277 $86.9 Million
Q1 2024

May 14, 2024
BUY
$27.46 - $31.33 $4.91 Million - $5.61 Million
178,958 Added 6.79%
2,813,133 $85.4 Million
Q4 2023

Feb 13, 2024
BUY
$26.21 - $29.22 $949,483 - $1.06 Million
36,226 Added 1.39%
2,634,175 $74 Million
Q3 2023

Nov 13, 2023
BUY
$26.26 - $31.38 $5.89 Million - $7.04 Million
224,261 Added 9.45%
2,597,949 $70.5 Million
Q2 2023

Aug 11, 2023
SELL
$29.6 - $36.56 $3.08 Million - $3.8 Million
-104,040 Reduced 4.2%
2,373,688 $73 Million
Q1 2023

May 15, 2023
BUY
$32.77 - $39.4 $1.58 Million - $1.9 Million
48,275 Added 1.99%
2,477,728 $89.3 Million
Q4 2022

Feb 13, 2023
BUY
$39.17 - $44.04 $3.09 Million - $3.47 Million
78,769 Added 3.35%
2,429,453 $96 Million
Q3 2022

Nov 14, 2022
SELL
$39.88 - $44.65 $1.29 Million - $1.44 Million
-32,350 Reduced 1.36%
2,350,684 $94.5 Million
Q2 2022

Aug 12, 2022
SELL
$37.53 - $44.22 $962,644 - $1.13 Million
-25,650 Reduced 1.06%
2,383,034 $100 Million
Q1 2022

May 13, 2022
BUY
$37.46 - $42.44 $5.51 Million - $6.24 Million
147,062 Added 6.5%
2,408,684 $93.8 Million
Q4 2021

Feb 08, 2022
BUY
$35.17 - $42.48 $20.9 Million - $25.2 Million
592,948 Added 35.53%
2,261,622 $90.1 Million
Q3 2021

Nov 15, 2021
BUY
$36.14 - $42.24 $16.3 Million - $19 Million
450,183 Added 36.95%
1,668,674 $60.3 Million
Q2 2021

Aug 13, 2021
SELL
$39.85 - $46.63 $3.47 Million - $4.06 Million
-87,142 Reduced 6.67%
1,218,491 $49.9 Million
Q1 2021

May 12, 2021
BUY
$42.34 - $52.82 $23.6 Million - $29.5 Million
558,274 Added 74.7%
1,305,633 $57 Million
Q4 2020

Feb 11, 2021
BUY
$36.12 - $50.05 $7.13 Million - $9.88 Million
197,318 Added 35.87%
747,359 $37.4 Million
Q3 2020

Nov 16, 2020
BUY
$38.56 - $48.36 $15.1 Million - $18.9 Million
391,165 Added 246.21%
550,041 $23.1 Million
Q2 2020

Aug 14, 2020
BUY
$44.5 - $52.11 $7.07 Million - $8.28 Million
158,876 New
158,876 $7.71 Million

Others Institutions Holding RPRX

# of Institutions
412
Shares Held
283M
Call Options Held
578K
Put Options Held
47.5K
View Full List

About Royalty Pharma plc

RPRX Quotes by TradingView
  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.2B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email